Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study, Journal of the Pediatric Infectious Diseases Society, March 2019, Oxford University Press (OUP),
DOI: 10.1093/jpids/piz010.
You can read the full text:
Contributors
The following have contributed to this page
